Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, Feb. 02, 2024 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical […]
United States Lime & Minerals Reports Fourth Quarter and Full Year 2023 Results and Declares Increased Regular Quarterly Cash Dividend
DALLAS, Feb. 02, 2024 (GLOBE NEWSWIRE) — United States Lime & Minerals, Inc. (NASDAQ: USLM) today reported fourth quarter and […]
MidWestOne Financial Group, Inc. Completes Acquisition of Denver Bankshares, Inc.
IOWA CITY, Iowa, Feb. 02, 2024 (GLOBE NEWSWIRE) — MidWestOne Financial Group, Inc. (Nasdaq: MOFG) (“MidWestOne” or the “Company”), parent […]
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
ALACHUA, Fla. and TAMPA, Fla., Feb. 02, 2024 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing […]
Bit Brother Limited Receives Notice of Delisting from Nasdaq
CHANGSHA, China, Feb. 02, 2024 (GLOBE NEWSWIRE) — Bit Brother Limited (“Bit Brother, ” “We” or the “Company”) (Nasdaq: BETS), today […]
Seth Schuknecht Appointed General Counsel, Corporate Secretary and Chief Compliance Officer of Cavco Industries, Inc.
PHOENIX, Feb. 02, 2024 (GLOBE NEWSWIRE) — Cavco Industries, Inc. (Nasdaq: CVCO) (“we,” “our,” the “Company” or “Cavco”) is pleased […]
Oxbridge Re Holdings Limited Announces Term Extension of Warrants
GRAND CAYMAN, Cayman Islands, Feb. 02, 2024 (GLOBE NEWSWIRE) — Oxbridge Re Holdings Limited (NASDAQ: OXBR), (the “Company”), which together […]
Zscaler to Host Second Quarter Fiscal Year 2024 Earnings Conference Call
SAN JOSE, Calif., Feb. 02, 2024 (GLOBE NEWSWIRE) — Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, will release […]
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Feb. 02, 2024 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing […]
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, Feb. 02, 2024 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights […]
